Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Statistics

Total Valuation

OVID has a market cap or net worth of $23.75 million. The enterprise value is -$14.38 million.

Market Cap	23.75M
Enterprise Value	-14.38M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

OVID has 71.08 million shares outstanding. The number of shares has increased by 0.46% in one year.

Current Share Class	71.08M
Shares Outstanding	71.08M
Shares Change (YoY)	+0.46%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	5.49%
Owned by Institutions (%)	43.30%
Float	50.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.19
Forward PS	60.18
PB Ratio	0.35
P/TBV Ratio	0.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.22.

Current Ratio	5.32
Quick Ratio	5.04
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.88% and return on invested capital (ROIC) is -39.07%.

Return on Equity (ROE)	-33.88%
Return on Assets (ROA)	-30.90%
Return on Invested Capital (ROIC)	-39.07%
Return on Capital Employed (ROCE)	-71.51%
Revenue Per Employee	$24,609
Profits Per Employee	-$1.13M
Employee Count	23
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.56% in the last 52 weeks. The beta is 0.44, so OVID's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-89.56%
50-Day Moving Average	0.43
200-Day Moving Average	0.88
Relative Strength Index (RSI)	48.24
Average Volume (20 Days)	483,155

Short Selling Information

The latest short interest is 1.21 million, so 1.70% of the outstanding shares have been sold short.

Short Interest	1.21M
Short Previous Month	1.06M
Short % of Shares Out	1.70%
Short % of Float	2.40%
Short Ratio (days to cover)	3.06

Income Statement

In the last 12 months, OVID had revenue of $566,000 and -$25.98 million in losses. Loss per share was -$0.37.

Revenue	566,000
Gross Profit	566,000
Operating Income	-58.39M
Pretax Income	-50.68M
Net Income	-25.98M
EBITDA	-57.77M
EBIT	-58.39M
Loss Per Share	-$0.37

Balance Sheet

The company has $53.08 million in cash and $14.76 million in debt, giving a net cash position of $38.32 million or $0.54 per share.

Cash & Cash Equivalents	53.08M
Total Debt	14.76M
Net Cash	38.32M
Net Cash Per Share	$0.54
Equity (Book Value)	68.23M
Book Value Per Share	0.96
Working Capital	45.42M

Cash Flow

In the last 12 months, operating cash flow was -$55.96 million and capital expenditures -$71,000, giving a free cash flow of -$56.03 million.

Operating Cash Flow	-55.96M
Capital Expenditures	-71,000
Free Cash Flow	-56.03M
FCF Per Share	-$0.79

Margins

Gross Margin	100.00%
Operating Margin	-10,315.37%
Pretax Margin	-4,670.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OVID does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.46%
Shareholder Yield	-0.46%
Earnings Yield	-108.51%
FCF Yield	-234.05%

Analyst Forecast

The average price target for OVID is $3.03, which is 806.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.03
Price Target Difference	806.64%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	171.98%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OVID has an Altman Z-Score of -2.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.47
Piotroski F-Score	1